JP2010533132A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010533132A5 JP2010533132A5 JP2010515363A JP2010515363A JP2010533132A5 JP 2010533132 A5 JP2010533132 A5 JP 2010533132A5 JP 2010515363 A JP2010515363 A JP 2010515363A JP 2010515363 A JP2010515363 A JP 2010515363A JP 2010533132 A5 JP2010533132 A5 JP 2010533132A5
- Authority
- JP
- Japan
- Prior art keywords
- diseases
- cancer
- treatment
- carcinoma
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007032739.2 | 2007-07-13 | ||
| DE102007032739A DE102007032739A1 (de) | 2007-07-13 | 2007-07-13 | Chinazolinamidderivate |
| PCT/EP2008/004846 WO2009010139A2 (de) | 2007-07-13 | 2008-06-16 | Chinazolinamidderivate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010533132A JP2010533132A (ja) | 2010-10-21 |
| JP2010533132A5 true JP2010533132A5 (enExample) | 2013-12-05 |
| JP5457343B2 JP5457343B2 (ja) | 2014-04-02 |
Family
ID=40121496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010515363A Expired - Fee Related JP5457343B2 (ja) | 2007-07-13 | 2008-06-16 | キナゾリンアミド誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8501754B2 (enExample) |
| EP (1) | EP2164833B1 (enExample) |
| JP (1) | JP5457343B2 (enExample) |
| KR (1) | KR20100044846A (enExample) |
| CN (1) | CN101743229B (enExample) |
| AR (1) | AR067506A1 (enExample) |
| AU (1) | AU2008278032B2 (enExample) |
| BR (1) | BRPI0814236A2 (enExample) |
| CA (1) | CA2694475C (enExample) |
| DE (1) | DE102007032739A1 (enExample) |
| EA (1) | EA017585B1 (enExample) |
| ES (1) | ES2538218T3 (enExample) |
| IL (1) | IL203206A (enExample) |
| WO (1) | WO2009010139A2 (enExample) |
| ZA (1) | ZA201001058B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008061214A1 (de) * | 2008-12-09 | 2010-06-10 | Merck Patent Gmbh | Chinazolinamidderivate |
| AR077405A1 (es) | 2009-07-10 | 2011-08-24 | Sanofi Aventis | Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer |
| FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
| CN102711749A (zh) * | 2009-11-05 | 2012-10-03 | 莱西肯医药有限公司 | 用于癌症治疗的色氨酸羟化酶抑制剂 |
| DE102009054302A1 (de) * | 2009-11-23 | 2011-05-26 | Merck Patent Gmbh | Chinazolinderivate |
| DE102010046837A1 (de) | 2010-09-29 | 2012-03-29 | Merck Patent Gmbh | Phenylchinazolinderivate |
| LT2643313T (lt) | 2010-11-24 | 2016-10-25 | Merck Patent Gmbh | Chinazolino karboksamido azetidinai |
| GB2486631A (en) * | 2010-12-01 | 2012-06-27 | Univ Sheffield | Phenol/quinone boronic acids/esters and method of preparation thereof |
| TW201311149A (zh) * | 2011-06-24 | 2013-03-16 | Ishihara Sangyo Kaisha | 有害生物防治劑 |
| WO2014143960A1 (en) * | 2013-03-15 | 2014-09-18 | Rexahn Pharmaceuticals, Inc. | Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl) methanone compounds as cancer cell growth inhibitors |
| EP3253390B1 (en) | 2015-02-06 | 2022-04-13 | Merck Sharp & Dohme Corp. | Aminoquinazoline compounds as a2a antagonist |
| EP3317278B1 (en) * | 2015-07-01 | 2021-04-14 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| JP6740354B2 (ja) | 2015-10-05 | 2020-08-12 | ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク | オートファジーの流れ及びホスホリパーゼｄ及びタウを含むタンパク質凝集体のクリアランスの活性化剤ならびにタンパク質症の治療方法 |
| TWI734806B (zh) * | 2016-07-19 | 2021-08-01 | 日商日本化藥股份有限公司 | 攝像元件用光電變換元件用材料及含有該材料之光電變換元件 |
| AU2018290511B2 (en) * | 2017-06-26 | 2022-01-27 | Sunshine Lake Pharma Co., Ltd. | Dihydropyrimidine compounds and uses thereof in medicine |
| CN107382976A (zh) * | 2017-07-04 | 2017-11-24 | 孙秀芹 | 一种治疗盆腔炎的化合物及制备方法和应用 |
| CN107488168A (zh) * | 2017-07-18 | 2017-12-19 | 黄绍菊 | 一种治疗盆腔炎的化合物及制备方法和应用 |
| EP3658560A4 (en) | 2017-07-25 | 2021-01-06 | Crinetics Pharmaceuticals, Inc. | SOMATOSTAT IN MODULATORS AND USES THEREOF |
| TWI853814B (zh) | 2018-05-31 | 2024-09-01 | 南韓商Ｃ＆Ｃ新藥研究所 | 雜環衍生物及其用途 |
| US20230250088A1 (en) * | 2020-07-15 | 2023-08-10 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| IL310724A (en) | 2021-08-10 | 2024-04-01 | Ifm Due Inc | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH STING ACTIVITY |
| WO2023244713A1 (en) * | 2022-06-16 | 2023-12-21 | Ensem Therapeutics, Inc. | Quinazoline derivatives, compositions and methods thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968921A (en) | 1997-10-24 | 1999-10-19 | Orgegon Health Sciences University | Compositions and methods for promoting nerve regeneration |
| AU3378599A (en) | 1998-04-03 | 1999-10-25 | University Of Pittsburgh | Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke |
| EP1161231A2 (en) | 1999-03-12 | 2001-12-12 | THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH | Method of inhibiting a chaperone protein |
| CA2429196A1 (en) | 2000-03-24 | 2001-10-04 | Duke University | Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| AU2001271567A1 (en) | 2000-06-29 | 2002-01-14 | Trustees Of Boston University | Use of geldanamycin and related compounds for prophylaxis or treatment of fibrogenic disorders |
| JP2004504356A (ja) | 2000-07-20 | 2004-02-12 | メルク エンド カムパニー インコーポレーテッド | Ｃ型肝炎ウイルスのプロセシングおよび複製の抑制 |
| ATE526019T1 (de) | 2000-07-28 | 2011-10-15 | Sloan Kettering Inst Cancer | Verfahren zur behandlung von zellproliferationen störungen und virusinfektionen |
| CN1300116C (zh) | 2001-04-16 | 2007-02-14 | 卫材株式会社 | 1h－吲唑化合物 |
| EP1450784A4 (en) | 2001-11-09 | 2005-02-09 | Conforma Therapeutics Corp | HSP90-INHIBITABLE ZEARALANOL COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE |
| WO2006010595A1 (en) | 2004-07-27 | 2006-02-02 | Novartis Ag | Inhibitors of hsp90 |
| US20070054916A1 (en) * | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| DE102005022977A1 (de) * | 2005-05-19 | 2006-12-07 | Merck Patent Gmbh | Phenylchinazolinderivate |
-
2007
- 2007-07-13 DE DE102007032739A patent/DE102007032739A1/de not_active Withdrawn
-
2008
- 2008-06-16 ES ES08773474T patent/ES2538218T3/es active Active
- 2008-06-16 EP EP08773474.5A patent/EP2164833B1/de not_active Not-in-force
- 2008-06-16 EA EA201000098A patent/EA017585B1/ru not_active IP Right Cessation
- 2008-06-16 AU AU2008278032A patent/AU2008278032B2/en not_active Ceased
- 2008-06-16 CA CA2694475A patent/CA2694475C/en not_active Expired - Fee Related
- 2008-06-16 BR BRPI0814236-0A2A patent/BRPI0814236A2/pt not_active IP Right Cessation
- 2008-06-16 CN CN2008800245618A patent/CN101743229B/zh not_active Expired - Fee Related
- 2008-06-16 US US12/668,864 patent/US8501754B2/en not_active Expired - Fee Related
- 2008-06-16 WO PCT/EP2008/004846 patent/WO2009010139A2/de not_active Ceased
- 2008-06-16 JP JP2010515363A patent/JP5457343B2/ja not_active Expired - Fee Related
- 2008-06-16 KR KR1020107003221A patent/KR20100044846A/ko not_active Withdrawn
- 2008-07-11 AR ARP080102977A patent/AR067506A1/es unknown
-
2010
- 2010-01-07 IL IL203206A patent/IL203206A/en not_active IP Right Cessation
- 2010-02-12 ZA ZA2010/01058A patent/ZA201001058B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010533132A5 (enExample) | ||
| JP2010516639A5 (enExample) | ||
| Kunnumakkara et al. | Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | |
| MX2019001302A (es) | Conjugados de farmaco con enlazadores autoestabilizantes que tienen propiedades fisioquimicas mejoradas. | |
| TW200640883A (en) | Compounds for the treatment of proliferative disorders | |
| CY1117440T1 (el) | Συτηκτα παραγωγα ιμιδαζολης ως αναστολεις toy ido | |
| AU2015231270B2 (en) | Antifungal compound process | |
| IL180979A (en) | Isoindulin compounds and their use | |
| BRPI0916356A2 (enExample) | ||
| EP3119754A1 (en) | Antifungal compound process | |
| WO2009066060A3 (en) | 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use | |
| JP2018527301A5 (ja) | アジリジン含有ｄｎａアルキル化剤 | |
| Huo et al. | 2-Arylindoles: concise syntheses and a privileged scaffold for fungicide discovery | |
| EA202090259A1 (ru) | Новые гетероариламидные производные как селективные ингибиторы гистондеацетилаз 1 и/или 2 (hdac1-2) | |
| TNSN07294A1 (en) | Treatment of metastasized tumors | |
| TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| MX2024002409A (es) | Terapias contra el cancer. | |
| Ozdemir et al. | Synthesis, anticonvulsant and antimicrobial activities of some new [1-(2-naphthyl)-2-(pyrazol-1-yl) ethanone] oxime ethers | |
| Ye et al. | Actively targeted delivery of doxorubicin to bone metastases by a pH-sensitive conjugation | |
| Movafagh et al. | Histone deacetylase inhibitors in cancer prevention and therapy | |
| JP2017511340A5 (enExample) | ||
| WO2007009721A3 (en) | Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments | |
| EA201270347A1 (ru) | Производные апогоссиполона в качестве противоопухолевых агентов | |
| WO2015081867A1 (zh) | 吉西他滨衍生物、含该衍生物的组合物及所述衍生物的制药用途 | |
| Hassan et al. | Synthesis and pharmacological profiling of mono imine Schiff bases: Dual anti-inflammatory and antibacterial activity with computational insights |